Aerpio Pharmaceuticals Inc (ARPO)

NASDAQ
1.125
+0.055(+5.14%)
  • Volume:
    463,630
  • Bid/Ask:
    1.12/1.13
  • Day's Range:
    1.09 - 1.15

ARPO Comments

What is your sentiment on Aerpio Pharmaceuticals Inc?
or
Vote to see community's results!

All Comments

(20)
  • I read the latest press release, looks like their drug didnt meet primary endpoint, though they hope to check it again during a month. Usually if primary endpoint is not reached then the drug is placebo.
    0
    • Do you think this will go back up anytime soon? Os there bad news for the compmany?
      0
      • do you think he will recover soon?
        0
        • all news is good,
          0
          • what's going on?
            0
            • wt
              0
              • wat the ******is going in after market .. 40 % down ?
                0
                • All Bio shares are down....
                  0
                  • Hmmm seems I was lucky to sell at 1.8
                    0
                    • 😂😂🤦👎
                      0
                      • 1.94 AM EXCELLENT 💪👌👍😊
                        2
                        • ARPO a small stock has given me 22% rise , that too on a day when all others have disappointed . Nova , Mrna , Bntx , Astra , Sanofi ... Seriously I salute to the guys running ARPO. .. its been so stable when all others are horribly unpredictable. ARPO has hd its base value and maintained its 1.5 level and Now its on 1.83 and after market is up again. highly recommended if someone wants to invest 1000 dollars and forget it for a while , I am sure its worth putting your 💰......
                          0
                          • 😊😊😊😊👌👌👌👌
                            0
                            • Yes ... Come on.........well done 💪
                              0
                              • Come on its time to brake through 1.70 Mark and plus 💪
                                0
                                • Buy Buy Buy.....going up 250% on Monday..
                                  0
                                  • bought at 1.47 👍
                                    0
                                    • Buy in Big quantity ... hurry up 👍
                                      1
                                      • I just sold all of mine for $1.52. I didn’t know all of the details. 😭
                                        0
                                      • Tejasvi Gognathanks for the response.
                                        0
                                      • Regina GriffinNano cap Aerpio Pharmaceuticals (NASDAQ:ARPO) jumps 52% premarket on robust volume in reaction to its announcement that the U.S. Army Medical Research and Development Command's Medical Technology Enterprise Consortium has agreed to provide up to $5.1M to support a Phase 2 clinical trial evaluating razuprotafib for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate-to-severe COVID-19. The company will contribute $2.8M to the study. The trial should be completed by Q1 2021.Razuprotafib (AKB-9778) 
                                        0
                                    • Any tips on how this stock will do today?
                                      0
                                      • pump and dump
                                        0
                                    • Why??
                                      0
                                      • https://finance.yahoo.com/news/aerpio-pharmaceuticals-inc-announces-second-201500148.html?guce_referrer=aHR0cHM6Ly9maW52aXouY29tL3F1b3RlLmFzaHg_dD1BUlBP&guce_referrer_sig=AQAAAM694epP3mfMkRwGi9sNXWBC8MFmSEJWzWkTnX6xs2EC0VBX0VVBFjgdvDdhOykfDvkzQiGphz1idjJrBNULnw9Yyi7p8ztKk79BmqF0vozyYyUunXiadrxWqi133ZPFraP6G5A1etza3kuA5qmimJKYosl2YMD_x8rE8i2BpvWj&_guc_consent_skip=1596619065
                                        0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.